Tech Company Financing Transactions
Circular Genomics Funding Round
Circular Genomics, based in Albuquerque, secured $8.3 million in funding from Mountain Group Partners, Cottonwood Technology Fund and Tramway Venture Partners.
Transaction Overview
Company Name
Announced On
1/24/2024
Transaction Type
Venture Equity
Amount
$8,300,000
Round
Series A
Investors
Mountain Group Partners (Lead Investor) (Joe Cook)
Proceeds Purpose
The new funding will enable Circular Genomics to build and scale commercial operations in preparation for the launch of the world's first circular RNA-based clinical assay.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
5901 Indian School Rd NE
Albuquerque, NM 87110
USA
Albuquerque, NM 87110
USA
Phone
Undisclosed
Website
Email Address
Overview
Circular Genomics is a pioneer in precision medicine, leveraging cutting-edge technology and proprietary data to uncover insights for personalized medicine. We're dedicated to advancing circular RNA biomarkers for accurate diagnosis and treatment of psychiatric and neurological disorders, aiming to empower individuals to gain deeper insights into their mental health and discover optimal treatment pathways.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Sargeant
Chief Financial Officer
Stephen McKernan
Chief Information Officer
Kosmas Karadimitriou
Chief Scientific Officer
Nikolaos Mellios
VP - Bus. Development
Dave Karlander
VP - R & D
Vishi Srinivasan
Browse more venture capital transactions:
Prev: 1/24/2024: HEPHAISTOS-Pharma venture capital transaction
Next: 1/24/2024: Anomalo venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs